Trump Floored as Novo Nordisk Executive Collapses During Oval Office Event
During a live press conference at the White House, Novo Nordisk executive Gordon Findlay unexpectedly collapsed while standing behind President Donald Trump. The event was focused on a new agreement related to weight-loss medications when the incident occurred.
Witnesses reported that Findlay's knees suddenly gave way, prompting administration officials and pharmaceutical representatives to rush forward and prevent him from falling to the ground.
Official White House Response
“During the Most Favored Nations Oval Office Announcement, a representative with one of the companies fainted. The White House Medical Unit quickly jumped into action, and the gentleman is okay. The Press Conference will resume shortly.”
White House Press Secretary Karoline Leavitt confirmed that Findlay was attended to immediately by on-site medics, who determined he was not seriously harmed. She emphasized that the press briefing would continue once the situation stabilized.
Witness Accounts
According to members of the press, Dr. Mehmet Oz, who currently oversees the Centers for Medicare & Medicaid Services, assisted Findlay to the ground to keep him from hitting his head. Reporters were later escorted out of the Oval Office while cabinet members and medical personnel provided care and elevated the executive’s legs.
Summary
During a high-profile White House announcement on weight-loss drug policy, Novo Nordisk executive Gordon Findlay fainted behind President Trump but recovered after prompt medical attention.